Natera Shares Plunge 8.3% After PPI Inflation Surpasses Forecast
Natera shares fell 8.3% after January’s Producer Price Index rose 0.5%, above the 0.3% forecast. Persistent producer inflation has raised expectations of delayed Federal Reserve rate cuts and higher borrowing costs, pressuring healthcare stock valuations.
1. Stock Drop After Inflation Data
Natera shares declined 8.3% in the afternoon session following the release of January’s Producer Price Index, which showed a 0.5% increase versus the 0.3% forecast. The stronger-than-expected inflation reading spooked investors, leading to a sell-off in healthcare and medical device stocks.
2. Implications for Borrowing Costs and Valuations
Persistently elevated producer inflation is fueling market fears that the Federal Reserve will postpone interest rate cuts, resulting in sustained higher borrowing costs. Higher rates can dampen corporate investment and earnings growth, exerting downward pressure on Natera’s valuation.
3. Historical Volatility and Recent Catalyst
Over the past year, Natera experienced 13 moves greater than 5%, highlighting its volatility. The largest swing was an 11.6% gain seven months ago after reporting Q2 2025 revenue of $546.6 million, up 32.2% year-over-year, and raising full-year guidance to $2.06 billion.